Agenus AGEN
NASDAQ AGEN
$8.32 +0.08 (+1.00%)
As of: Sep 4, 2026 · 1:39 PM EDT

Agenus (AGEN) Income towards Parent Company (2010 - 2026)

Agenus (AGEN) posted quarterly Income towards Parent Company of $364000.0 for Q1 2026, up 101.38% year-over-year from $180748.9 in Q1 2025, and up 122.05% quarter-over-quarter from -$1.7 million in Q4 2025.

Analysis

Agenus (AGEN) Income towards Parent Company (2010 - 2026) Analysis & Trends

Agenus' Income towards Parent Company history runs 17 years deep, the most recent figure standing at $364000.0 for Q1 2026.

  • In Q1 2026, Income towards Parent Company rose 101.38% year-over-year to $364000.0; the TTM figure through Mar 2026 stood at -$38.3 million (up 81.22% YoY), while the FY2025 annual figure was -$415.1 million, up 20.05% from the prior year.
  • Income towards Parent Company for Q1 2026 stood at $364000.0, up from -$1.7 million in the prior quarter.
  • The five-year high for Income towards Parent Company was $364000.0 in Q1 2026, with the low at -$105.5 million in Q4 2023.
  • The 5-year median for Income towards Parent Company is -$46.7 million (2023), against an average of -$44.1 million.
  • The sharpest annual moves came in 2022 and 2026: Income towards Parent Company plunged 131.71% in 2022, then soared 101.38% in 2026.
  • Agenus' Income towards Parent Company stood at -$58.1 million in 2022, then plunged by 81.78% to -$105.5 million in 2023, then jumped by 55.45% to -$47.0 million in 2024, then jumped by 96.49% to -$1.7 million in 2025, then surged by 122.05% to $364000.0 in 2026.
  • Business Quant data shows AGEN's Income towards Parent Company at $364000.0 in Q1 2026, -$1.7 million in Q4 2025, and -$7.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Agenus 344.35 Mn 344.35 Mn 34.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.95 Mn
Mar 31, 2026 385,000.00
Dec 31, 2025 -1.62 Mn
Sep 30, 2025 -17.72 Mn
Jun 30, 2025 -30.00 Mn
Mar 31, 2025 -26.11 Mn
Dec 31, 2024 -46.58 Mn
Sep 30, 2024 -67.23 Mn
Jun 30, 2024 -61.94 Mn
Mar 31, 2024 -62.35 Mn
Dec 31, 2023 -48.38 Mn
Sep 30, 2023 -64.97 Mn
Jun 30, 2023 -73.19 Mn
Mar 31, 2023 -70.93 Mn
Dec 31, 2022 -75.08 Mn
Sep 30, 2022 -57.25 Mn
Jun 30, 2022 -58.30 Mn
Mar 31, 2022 -50.66 Mn
Dec 31, 2021 -70.60 Mn
Sep 30, 2021 170.96 Mn